Admedus will need capital.
When you look at capital requirements to develop,complete trials and bring a pharmaceutical to market, (around 1 billion dollars per product) , then I doubt CC sales will fund the programme for a few years yet.
So despite the company operating frugally ,compared to a large pharmaceutical ,they will need another CR. I do not think that is a bad thing and if phase II vaccine trials are successful it should be oversubscribed and at a much higher SP.
Buying medical stocks is a high risk business as 98% of pharmaceuticals fail. The large pharmaceuticals have to be very discerning and factor this failure rate into the cost of the few successful ones.
Admedus is at a great advantage as they already have a proven technology in CC and now only need total market acceptance which will take time and money.
The uncertainty and risk is if the vaccine trial fails ,will the company be able to attract enough capital to continue marketing CC to profit.
- Forums
- ASX - By Stock
- Company moves to bigger grounds!
Admedus will need capital. When you look at capital requirements...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M |
Open | High | Low | Value | Volume |
$18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60 | $17.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.05 | 554 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 17.880 |
1 | 47 | 17.870 |
1 | 619 | 17.860 |
1 | 37 | 17.650 |
2 | 700 | 17.550 |
Price($) | Vol. | No. |
---|---|---|
18.050 | 554 | 1 |
18.100 | 1000 | 1 |
18.200 | 343 | 2 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online